Targeted sequencing involves sequencing a small region or set of regions of the genome, such as particular chromosomes, exomes, or individual genes of scientific or clinical interest. This is a highly cost-effective alternative to whole genome sequencing Targeted sequencing is at the forefront of cancer research and treatment. By sequencing known genes of clinical relevance, mutations can be detected which may influence response to a treatment
Unrivalled Data Quality
Rapid Turnaround Times
Scalable
Global provider from ISO-accredited labs
How to Order
Contact us today and one of our skilled account managers will be in touch with a free consultation including further information and pricing details.
Next Generation Sequencing
Source BioScience is one of Europe’s leading providers of commercial sequencing, offering Next Generation Sequencing services from our ISO accredited laboratories. We offer NGS services on the most prominent platforms including Illumina’s NovaSeq, NextSeq and MiSeq.